
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
        <meta name="description" content="Clinical decision support for tardive dyskinesia evaluation, prevention, and management">
      
      
      
        <link rel="canonical" href="https://blondarb.github.io/neuro-plans/drafts/tardive-dyskinesia/">
      
      
      
      
        
      
      
      <link rel="icon" href="../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.7.1">
    
    
      
        <title>Tardive Dyskinesia - Neuro Clinical Plans</title>
      
    
    
      <link rel="stylesheet" href="../../assets/stylesheets/main.484c7ddc.min.css">
      
        
        <link rel="stylesheet" href="../../assets/stylesheets/palette.ab4e12ef.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../../assets/css/custom.css">
    
    <script>__md_scope=new URL("../..",location),__md_hash=e=>[...e].reduce(((e,_)=>(e<<5)-e+_.charCodeAt(0)),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#tardive-dyskinesia" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

  

<header class="md-header md-header--shadow" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../.." title="Neuro Clinical Plans" class="md-header__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3zm0 5h18v2H3zm0 5h18v2H3z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Neuro Clinical Plans
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Tardive Dyskinesia
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a4 4 0 0 0-4 4 4 4 0 0 0 4 4 4 4 0 0 0 4-4 4 4 0 0 0-4-4m0 10a6 6 0 0 1-6-6 6 6 0 0 1 6-6 6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 18c-.89 0-1.74-.2-2.5-.55C11.56 16.5 13 14.42 13 12s-1.44-4.5-3.5-5.45C10.26 6.2 11.11 6 12 6a6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var palette=__md_get("__palette");if(palette&&palette.color){if("(prefers-color-scheme)"===palette.color.media){var media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']");palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent")}for(var[key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      
      
        <label class="md-header__button md-icon" for="__search">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        </label>
        <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"/></svg>
        </button>
      </nav>
      
        <div class="md-search__suggest" data-md-component="search-suggest"></div>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
      
    
    
      <div class="md-header__source">
        <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    



<nav class="md-nav md-nav--primary" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../.." title="Neuro Clinical Plans" class="md-nav__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    Neuro Clinical Plans
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../.." class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Home
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../clinical/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Interactive Clinical Tool
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--section md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3" >
        
          
          <label class="md-nav__link" for="__nav_3" id="__nav_3_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    Clinical Plans
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Clinical Plans
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Overview
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_2" >
        
          
          <label class="md-nav__link" for="__nav_3_2" id="__nav_3_2_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Seizures & Epilepsy
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_2_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_2">
            <span class="md-nav__icon md-icon"></span>
            
  
    Seizures & Epilepsy
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/status-epilepticus/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Status Epilepticus
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/new-onset-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    New Onset Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/breakthrough-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Breakthrough Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_3" >
        
          
          <label class="md-nav__link" for="__nav_3_3" id="__nav_3_3_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Stroke & Vascular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Stroke & Vascular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/acute-ischemic-stroke/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Ischemic Stroke
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/transient-ischemic-attack/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Transient Ischemic Attack
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/intracerebral-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Intracerebral Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/subarachnoid-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Subarachnoid Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_4" >
        
          
          <label class="md-nav__link" for="__nav_3_4" id="__nav_3_4_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuromuscular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/guillain-barre-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Guillain-Barré Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/myasthenia-gravis-crisis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenic Crisis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/myasthenia-gravis-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenia Gravis - New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/neuromuscular-respiratory-failure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular Respiratory Failure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/peripheral-neuropathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Peripheral Neuropathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_5" >
        
          
          <label class="md-nav__link" for="__nav_3_5" id="__nav_3_5_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    CNS Infections
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_5_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_5">
            <span class="md-nav__icon md-icon"></span>
            
  
    CNS Infections
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/bacterial-meningitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Bacterial Meningitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/hsv-encephalitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    HSV Encephalitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/autoimmune-encephalitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Autoimmune Encephalitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_6" >
        
          
          <label class="md-nav__link" for="__nav_3_6" id="__nav_3_6_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Spinal Emergencies
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_6_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_6">
            <span class="md-nav__icon md-icon"></span>
            
  
    Spinal Emergencies
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/acute-myelopathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Myelopathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/spinal-cord-compression-malignant/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Spinal Cord Compression (Malignant)
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/cauda-equina-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Cauda Equina Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/epidural-abscess/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Epidural Abscess
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_7" >
        
          
          <label class="md-nav__link" for="__nav_3_7" id="__nav_3_7_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuro-Oncology
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_7_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_7">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuro-Oncology
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/brain-metastases/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Brain Metastases
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_8" >
        
          
          <label class="md-nav__link" for="__nav_3_8" id="__nav_3_8_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Critical Care
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_8_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_8">
            <span class="md-nav__icon md-icon"></span>
            
  
    Critical Care
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/elevated-icp-management/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Elevated ICP Management
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_9" >
        
          
          <label class="md-nav__link" for="__nav_3_9" id="__nav_3_9_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Demyelinating
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_9_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_9">
            <span class="md-nav__icon md-icon"></span>
            
  
    Demyelinating
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/ms-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    MS New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_10" >
        
          
          <label class="md-nav__link" for="__nav_3_10" id="__nav_3_10_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Other
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_10_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_10">
            <span class="md-nav__icon md-icon"></span>
            
  
    Other
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/rapidly-progressive-dementia/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Rapidly Progressive Dementia
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/vertigo-dizziness-evaluation/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Vertigo / Dizziness
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--section md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_4" >
        
          
          <label class="md-nav__link" for="__nav_4" id="__nav_4_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    References
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    References
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/lp-reference/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    LP Reference
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/tracker/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Template Tracker
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#section-a-action-items" class="md-nav__link">
    <span class="md-ellipsis">
      
        SECTION A: ACTION ITEMS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#1-laboratory-workup" class="md-nav__link">
    <span class="md-ellipsis">
      
        1. LABORATORY WORKUP
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#2-diagnostic-imaging-studies" class="md-nav__link">
    <span class="md-ellipsis">
      
        2. DIAGNOSTIC IMAGING &amp; STUDIES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#3-treatment" class="md-nav__link">
    <span class="md-ellipsis">
      
        3. TREATMENT
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#4-other-recommendations" class="md-nav__link">
    <span class="md-ellipsis">
      
        4. OTHER RECOMMENDATIONS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#section-b-reference" class="md-nav__link">
    <span class="md-ellipsis">
      
        SECTION B: REFERENCE
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#5-differential-diagnosis" class="md-nav__link">
    <span class="md-ellipsis">
      
        5. DIFFERENTIAL DIAGNOSIS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#6-monitoring-parameters" class="md-nav__link">
    <span class="md-ellipsis">
      
        6. MONITORING PARAMETERS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#7-disposition-criteria" class="md-nav__link">
    <span class="md-ellipsis">
      
        7. DISPOSITION CRITERIA
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#8-evidence-references" class="md-nav__link">
    <span class="md-ellipsis">
      
        8. EVIDENCE &amp; REFERENCES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#change-log" class="md-nav__link">
    <span class="md-ellipsis">
      
        CHANGE LOG
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-a-aims-abnormal-involuntary-movement-scale-examination" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX A: AIMS (Abnormal Involuntary Movement Scale) Examination
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-b-causative-agents-and-risk-factors" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX B: Causative Agents and Risk Factors
      
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              
              <article class="md-content__inner md-typeset">
                
                  

  <nav class="md-tags" >
    
      
      
      
      
        <a href="../../tags/#tag:antipsychotics" class="md-tag">antipsychotics</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:drug-induced" class="md-tag">drug-induced</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:movement-disorders" class="md-tag">movement-disorders</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:outpatient" class="md-tag">outpatient</a>
      
    
  </nav>


  
  


<div class="draft-warning-banner">
  <div class="icon">⚠️</div>
  <div class="content">
    <div class="title">DRAFT - Pending Review</div>
    <div class="description">This plan requires physician review before clinical use.</div>
  </div>
</div>

<h1 id="tardive-dyskinesia">Tardive Dyskinesia<a class="headerlink" href="#tardive-dyskinesia" title="Permanent link">&para;</a></h1>
<p><strong>DIAGNOSIS:</strong> Tardive Dyskinesia
<strong>ICD-10:</strong> G24.01 (Drug-induced tardive dyskinesia); G24.02 (Drug-induced acute dystonia); G24.09 (Drug-induced dystonia, unspecified)
<strong>SYNONYMS:</strong> TD, tardive syndrome, tardive movement disorder, persistent tardive syndrome
<strong>SCOPE:</strong> Diagnosis confirmation, severity assessment using AIMS, identification of causative agents, risk factor evaluation, FDA-approved VMAT2 inhibitor therapy, antipsychotic management strategies, prevention, and psychiatric coordination. Covers classic orofacial-lingual TD, tardive dystonia, tardive akathisia, and tardive stereotypy.</p>
<p><strong>STATUS:</strong> Draft - Pending Review</p>
<hr />
<p><strong>PRIORITY KEY:</strong> STAT = Immediate | URGENT = Within hours | ROUTINE = Standard | EXT = Extended/atypical cases | - = Not applicable to this setting</p>
<hr />
<h2 id="section-a-action-items">SECTION A: ACTION ITEMS<a class="headerlink" href="#section-a-action-items" title="Permanent link">&para;</a></h2>
<hr />
<h2 id="1-laboratory-workup">1. LABORATORY WORKUP<a class="headerlink" href="#1-laboratory-workup" title="Permanent link">&para;</a></h2>
<h3 id="1a-essentialcore-labs">1A. Essential/Core Labs<a class="headerlink" href="#1a-essentialcore-labs" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>CMP (comprehensive metabolic panel)</td>
<td>Baseline renal/hepatic function before VMAT2 inhibitor therapy; electrolyte abnormalities can worsen movements</td>
<td>Normal</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>CBC with differential</td>
<td>Baseline for medication monitoring; rule out infection if acute change</td>
<td>Normal</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>TSH</td>
<td>Thyroid dysfunction can cause or exacerbate movement disorders</td>
<td>Normal (0.4-4.0 mIU/L)</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Medication and dose history review</td>
<td>Identify causative agent(s): antipsychotics, metoclopramide, prochlorperazine, other dopamine blockers</td>
<td>Document agent, duration, cumulative dose</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="1b-extended-workup-second-line">1B. Extended Workup (Second-line)<a class="headerlink" href="#1b-extended-workup-second-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ceruloplasmin, serum copper</td>
<td>Rule out Wilson's disease if age &lt;50 or atypical presentation</td>
<td>Normal</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>24-hour urine copper</td>
<td>Wilson's disease confirmation if ceruloplasmin low or borderline</td>
<td>&lt;100 μg/24hr</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Vitamin B12, folate</td>
<td>Deficiency can cause movement disorders</td>
<td>Normal</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Iron studies (ferritin, serum iron, TIBC)</td>
<td>Rule out brain iron accumulation disorders</td>
<td>Normal</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CK (creatine kinase)</td>
<td>If concern for neuroleptic malignant syndrome or severe dystonia</td>
<td>Normal</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Antipsychotic drug level</td>
<td>Assess compliance and toxicity if indicated</td>
<td>Therapeutic range</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="1c-rarespecialized-refractory-or-atypical">1C. Rare/Specialized (Refractory or Atypical)<a class="headerlink" href="#1c-rarespecialized-refractory-or-atypical" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Huntington disease genetic testing (HTT CAG repeats)</td>
<td>Chorea with psychiatric history; family history</td>
<td>&lt;36 CAG repeats (normal)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Acanthocyte smear</td>
<td>Neuroacanthocytosis if orofacial dyskinesia with chorea</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Paraneoplastic antibody panel</td>
<td>Atypical movement disorder; occult malignancy; autoimmune chorea</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Anti-NMDA receptor antibodies</td>
<td>Young patient; psychiatric symptoms; orofacial dyskinesia</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>SLC6A3 genetic testing (DAT-1)</td>
<td>Research; consider if dopamine transporter dysfunction suspected</td>
<td>Normal</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="2-diagnostic-imaging-studies">2. DIAGNOSTIC IMAGING &amp; STUDIES<a class="headerlink" href="#2-diagnostic-imaging-studies" title="Permanent link">&para;</a></h2>
<h3 id="2a-essentialfirst-line">2A. Essential/First-line<a class="headerlink" href="#2a-essentialfirst-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>AIMS (Abnormal Involuntary Movement Scale)</td>
<td>At evaluation; before treatment; q3-6 months on antipsychotics</td>
<td>Document baseline severity (0-4 scale per item; total score)</td>
<td>None</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Clinical examination (orofacial, trunk, limbs)</td>
<td>At evaluation</td>
<td>Characterize movement type, distribution, severity</td>
<td>None</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Video documentation</td>
<td>At baseline and follow-up</td>
<td>Record for comparison; share with psychiatry</td>
<td>Patient consent</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="2b-extended">2B. Extended<a class="headerlink" href="#2b-extended" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRI Brain</td>
<td>Atypical presentation; focal findings; rule out structural lesion</td>
<td>Normal or chronic dopaminergic medication changes</td>
<td>MRI-incompatible devices</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>DaTscan (ioflupane I-123)</td>
<td>Differentiate from Parkinson's disease or Huntington's if uncertain</td>
<td>Normal or mild reduction (dopamine blockers can affect)</td>
<td>Iodine hypersensitivity</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="2c-rarespecialized">2C. Rare/Specialized<a class="headerlink" href="#2c-rarespecialized" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRI Brain with SWI sequence</td>
<td>Suspected brain iron accumulation (NBIA)</td>
<td>No abnormal iron deposition</td>
<td>MRI contraindications</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>PET scan (FDG or dopamine receptor imaging)</td>
<td>Research; atypical cases</td>
<td>Variable</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Slit lamp examination</td>
<td>Wilson's disease evaluation</td>
<td>No Kayser-Fleischer rings</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>EMG</td>
<td>Characterize tremor vs dystonic movements</td>
<td>Define movement characteristics</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="3-treatment">3. TREATMENT<a class="headerlink" href="#3-treatment" title="Permanent link">&para;</a></h2>
<h3 id="3a-acuteemergent">3A. Acute/Emergent<a class="headerlink" href="#3a-acuteemergent" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Discontinue or reduce causative agent</td>
<td>N/A</td>
<td>First step if psychiatrically safe; requires psychiatry coordination</td>
<td>N/A :: N/A :: :: Collaborate with psychiatry; gradual taper preferred if stopping; dose reduction may help</td>
<td>Cannot discontinue if psychosis relapse risk too high</td>
<td>Monitor for psychiatric decompensation</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Switch to clozapine</td>
<td>PO</td>
<td>Lowest TD risk; for patients requiring continued antipsychotic</td>
<td>12.5 mg qHS; 25 mg BID; 50 mg BID; 100 mg BID :: PO :: :: Start 12.5-25 mg/day; titrate by 25-50 mg q3-7d; target 200-450 mg/day; requires REMS</td>
<td>Agranulocytosis history; severe neutropenia; seizure disorder (relative)</td>
<td>ANC weekly x 6mo, q2wk x 6mo, then monthly; seizures; myocarditis</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Switch to quetiapine</td>
<td>PO</td>
<td>Lower TD risk; for patients requiring continued antipsychotic</td>
<td>25 mg BID; 50 mg BID; 100 mg BID; 200 mg BID :: PO :: :: Start 25-50 mg BID; titrate by 50-100 mg/day q2-3d; target 300-800 mg/day</td>
<td>QT prolongation; severe hepatic impairment</td>
<td>QTc, sedation, metabolic parameters</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Benzodiazepine (severe distress)</td>
<td>PO/IV</td>
<td>Severe anxiety/distress from TD movements; temporary relief</td>
<td>0.5 mg TID; 1 mg TID :: PO :: :: Lorazepam 0.5-1 mg TID PRN for acute distress; short-term only</td>
<td>Respiratory depression; substance use disorder</td>
<td>Sedation, respiratory status</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
</tr>
</tbody>
</table>
<h3 id="3b-symptomatic-treatments-fda-approved-for-td">3B. Symptomatic Treatments (FDA-Approved for TD)<a class="headerlink" href="#3b-symptomatic-treatments-fda-approved-for-td" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Valbenazine (Ingrezza)</td>
<td>PO</td>
<td>FDA-approved first-line for TD; VMAT2 inhibitor</td>
<td>40 mg daily; 80 mg daily :: PO :: :: Start 40 mg once daily; increase to 80 mg daily after 1 week if tolerated; take with or without food</td>
<td>Congenital long QT; strong CYP2D6 inhibitors at higher dose; severe hepatic impairment</td>
<td>QTc (baseline, after dose increase); somnolence; depression</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Deutetrabenazine (Austedo)</td>
<td>PO</td>
<td>FDA-approved first-line for TD; VMAT2 inhibitor</td>
<td>6 mg BID; 9 mg BID; 12 mg BID :: PO :: :: Start 6 mg BID (12 mg/day); increase by 6 mg/day weekly; max 48 mg/day; take with food</td>
<td>Depression/suicidality; MAO-I use; hepatic impairment; reserpine use within 20 days</td>
<td>Depression (PHQ-9); parkinsonism; QTc; akathisia</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Tetrabenazine (Xenazine)</td>
<td>PO</td>
<td>VMAT2 inhibitor; older agent with more side effects</td>
<td>12.5 mg daily; 12.5 mg BID; 12.5 mg TID; 25 mg TID :: PO :: :: Start 12.5 mg daily; increase by 12.5 mg q1wk; max 50 mg/day (100 mg if CYP2D6 extensive metabolizer); require CYP2D6 genotyping &gt;50 mg</td>
<td>Depression/suicidality; untreated or inadequately treated depression</td>
<td>Depression (PHQ-9); parkinsonism; akathisia; sedation; requires CYP2D6 genotyping</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="3c-second-linerefractory">3C. Second-line/Refractory<a class="headerlink" href="#3c-second-linerefractory" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Clonazepam</td>
<td>PO</td>
<td>Adjunct for TD; limited evidence; reduces choreiform movements</td>
<td>0.25 mg BID; 0.5 mg BID; 1 mg BID :: PO :: :: Start 0.25 mg BID; titrate slowly; typical 0.5-4 mg/day divided</td>
<td>Respiratory depression; substance use disorder</td>
<td>Sedation, dependence, falls</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Amantadine</td>
<td>PO</td>
<td>Limited evidence; may reduce TD severity; antiglutamatergic</td>
<td>100 mg BID; 100 mg TID; 200 mg BID :: PO :: :: Start 100 mg BID; may increase to 300-400 mg/day divided; adjust for renal function</td>
<td>Severe renal impairment; seizure history (relative)</td>
<td>Livedo reticularis; edema; hallucinations; confusion (elderly)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Ginkgo biloba</td>
<td>PO</td>
<td>Limited evidence; antioxidant mechanism; modest benefit in trials</td>
<td>120 mg BID; 240 mg daily :: PO :: :: 240 mg/day divided; EGb 761 extract standardized</td>
<td>Bleeding disorders; anticoagulant use</td>
<td>Bleeding risk</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Vitamin E</td>
<td>PO</td>
<td>Limited evidence; may prevent progression; minimal therapeutic effect</td>
<td>400 IU daily; 800 IU daily :: PO :: :: 400-1600 IU daily; better evidence for prevention than treatment</td>
<td>Coagulopathy; vitamin K deficiency</td>
<td>Bleeding risk at high doses</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Vitamin B6 (pyridoxine)</td>
<td>PO</td>
<td>Limited evidence; some trials show benefit</td>
<td>100 mg daily; 200 mg daily :: PO :: :: 100-400 mg daily; monitor for neuropathy at high doses</td>
<td>Peripheral neuropathy</td>
<td>Neuropathy with chronic high dose (&gt;200 mg)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Levetiracetam</td>
<td>PO</td>
<td>Limited evidence; case reports of benefit</td>
<td>500 mg BID; 750 mg BID; 1000 mg BID :: PO :: :: Start 500 mg BID; titrate to 1500-3000 mg/day; adjust for renal function</td>
<td>Severe renal impairment without adjustment</td>
<td>Mood changes; sedation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Propranolol</td>
<td>PO</td>
<td>For tardive akathisia component</td>
<td>10 mg TID; 20 mg TID; 40 mg TID :: PO :: :: Start 10 mg TID; titrate to 30-120 mg/day divided</td>
<td>Asthma; bradycardia; heart block</td>
<td>HR, BP</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="3d-interventionaladvanced-therapies">3D. Interventional/Advanced Therapies<a class="headerlink" href="#3d-interventionaladvanced-therapies" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Pre-Treatment Requirements</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Botulinum toxin (focal TD)</td>
<td>IM</td>
<td>Focal tardive dystonia (e.g., cervical, blepharospasm)</td>
<td>Dose varies by target :: IM :: :: Cervical: 100-300 units; blepharospasm: 25-50 units per eye; repeat q3mo</td>
<td>EMG guidance recommended for some targets</td>
<td>Active infection at site; myasthenia gravis</td>
<td>Dysphagia (cervical); ptosis (periocular); local weakness</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Deep brain stimulation (DBS)</td>
<td>Surgical</td>
<td>Severe, disabling, medication-refractory TD</td>
<td>GPi (globus pallidus internus) target :: Surgical :: :: Bilateral GPi most common; programming optimization over months</td>
<td>MRI; neuropsychological testing; multidisciplinary evaluation; psychiatry clearance</td>
<td>Untreated psychiatric instability; cognitive impairment; coagulopathy</td>
<td>Programming; psychiatric monitoring; speech/swallowing</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Pallidal lesioning</td>
<td>Surgical</td>
<td>Alternative to DBS if not candidate; irreversible</td>
<td>Unilateral pallidotomy :: Surgical :: :: Stereotactic lesion of GPi; reserved for DBS failures or contraindications</td>
<td>Same as DBS</td>
<td>Same as DBS</td>
<td>Permanent side effect risk higher than DBS</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="4-other-recommendations">4. OTHER RECOMMENDATIONS<a class="headerlink" href="#4-other-recommendations" title="Permanent link">&para;</a></h2>
<h3 id="4a-referrals-consults">4A. Referrals &amp; Consults<a class="headerlink" href="#4a-referrals-consults" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Psychiatry consultation for antipsychotic management, dose reduction, or switch to lower-risk agent (ESSENTIAL - requires collaborative decision-making)</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Movement disorders neurology for diagnosis confirmation, AIMS scoring, and VMAT2 inhibitor initiation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Neurosurgery consultation for DBS evaluation if medication-refractory disabling TD</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Speech therapy for dysphagia evaluation if oropharyngeal involvement</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Occupational therapy for adaptive strategies if hand involvement affects function</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Social work for disability evaluation and resources if TD causes functional impairment</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Dentistry for oral health evaluation with orofacial TD (tooth damage, denture issues)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="4b-patient-instructions">4B. Patient Instructions<a class="headerlink" href="#4b-patient-instructions" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
</tr>
</thead>
<tbody>
<tr>
<td>Report any worsening movements, difficulty swallowing, or breathing problems immediately (may indicate progression)</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Do not stop antipsychotic medications without psychiatry guidance as this can worsen psychosis or cause withdrawal dyskinesia</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Report any new or worsening depression, suicidal thoughts, or mood changes on VMAT2 inhibitors (boxed warning)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Movements may temporarily worsen after stopping causative drug before improving (withdrawal dyskinesia)</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>VMAT2 inhibitors may take 2-6 weeks to show maximum benefit; continue as prescribed</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Avoid caffeine and stimulants which may worsen involuntary movements</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Maintain regular dental visits for oral health if orofacial TD present (prevents tooth damage, ulceration)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Consider support groups and counseling for coping with visible movement disorder</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<h3 id="4c-lifestyle-prevention">4C. Lifestyle &amp; Prevention<a class="headerlink" href="#4c-lifestyle-prevention" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
</tr>
</thead>
<tbody>
<tr>
<td>Use lowest effective antipsychotic dose for shortest duration needed (primary prevention)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Perform AIMS examination at baseline, 3 months, 6 months, then q6-12 months on dopamine-blocking agents</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Prefer second-generation antipsychotics over first-generation when clinically appropriate (lower TD risk)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Avoid metoclopramide for &gt;12 weeks; use domperidone or other alternatives when possible (not available in US)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Document informed consent regarding TD risk when starting dopamine-blocking agents</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Identify and monitor high-risk patients more frequently: elderly, female, mood disorders, diabetes, longer exposure, higher cumulative dose</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Consider early intervention with VMAT2 inhibitors before TD becomes severe and irreversible</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Stress management and adequate sleep may help reduce movement severity</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="section-b-reference">SECTION B: REFERENCE<a class="headerlink" href="#section-b-reference" title="Permanent link">&para;</a></h2>
<hr />
<h2 id="5-differential-diagnosis">5. DIFFERENTIAL DIAGNOSIS<a class="headerlink" href="#5-differential-diagnosis" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Alternative Diagnosis</th>
<th>Key Distinguishing Features</th>
<th>Tests to Differentiate</th>
</tr>
</thead>
<tbody>
<tr>
<td>Huntington disease</td>
<td>Family history; cognitive decline; chorea; CAG expansion</td>
<td>Genetic testing for HTT CAG repeats</td>
</tr>
<tr>
<td>Sydenham chorea</td>
<td>History of rheumatic fever; anti-streptolysin O; younger patients</td>
<td>ASO titer; echocardiogram</td>
</tr>
<tr>
<td>Withdrawal dyskinesia</td>
<td>Occurs immediately after stopping dopamine blocker; self-limited (&lt;3 months)</td>
<td>History; timeline (TD persists &gt;3 months)</td>
</tr>
<tr>
<td>Spontaneous orofacial dyskinesia (elderly)</td>
<td>Elderly without antipsychotic exposure; edentulous</td>
<td>Careful medication history; dental exam</td>
</tr>
<tr>
<td>Wilson disease</td>
<td>Age &lt;50; Kayser-Fleischer rings; liver disease; psychiatric symptoms</td>
<td>Ceruloplasmin; 24h urine copper; slit lamp</td>
</tr>
<tr>
<td>Neuroacanthocytosis</td>
<td>Orofacial dyskinesia; chorea; self-mutilation; elevated CK; acanthocytes</td>
<td>Acanthocyte smear; CK; genetic testing</td>
</tr>
<tr>
<td>Autoimmune chorea (anti-NMDA, anti-LGI1)</td>
<td>Subacute onset; psychiatric symptoms; seizures; encephalopathy</td>
<td>Autoimmune antibody panels; CSF</td>
</tr>
<tr>
<td>Meige syndrome (primary cranial dystonia)</td>
<td>Blepharospasm and oromandibular dystonia without antipsychotic exposure</td>
<td>Clinical history; no dopamine blocker use</td>
</tr>
<tr>
<td>Tourette syndrome</td>
<td>Childhood onset; tics (brief, suppressible); premonitory urge</td>
<td>Clinical criteria; onset &lt;18 years</td>
</tr>
<tr>
<td>Drug-induced acute dystonia</td>
<td>Occurs within days of drug exposure; not persistent</td>
<td>Timeline (acute dystonia is immediate, TD delayed)</td>
</tr>
<tr>
<td>Parkinson disease dyskinesia</td>
<td>History of Parkinson's; peak-dose or diphasic dyskinesia on levodopa</td>
<td>Clear PD diagnosis; levodopa relationship</td>
</tr>
<tr>
<td>Hyperthyroidism</td>
<td>Tremor predominant; tachycardia; weight loss; heat intolerance</td>
<td>TSH, free T4</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="6-monitoring-parameters">6. MONITORING PARAMETERS<a class="headerlink" href="#6-monitoring-parameters" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Parameter</th>
<th>Frequency</th>
<th>Target/Threshold</th>
<th>Action if Abnormal</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>AIMS score</td>
<td>Baseline, 3mo, 6mo, then q6-12mo on antipsychotics</td>
<td>Improvement from baseline (decrease of 2+ points clinically meaningful)</td>
<td>Adjust treatment; consider VMAT2 inhibitor</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>AIMS score on VMAT2 inhibitor</td>
<td>q4-8 weeks until stable, then q3-6mo</td>
<td>50%+ improvement goal; any improvement beneficial</td>
<td>Optimize dose; consider second agent</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Depression screen (PHQ-9)</td>
<td>Baseline, 2wk, 4wk, then q3mo on VMAT2 inhibitors</td>
<td>PHQ-9 &lt;5</td>
<td>Hold VMAT2 inhibitor; psychiatry consultation; consider switch</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Suicidality assessment</td>
<td>Each visit on VMAT2 inhibitors</td>
<td>No suicidal ideation</td>
<td>Immediate psychiatry referral; hold medication</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>QTc interval</td>
<td>Baseline, after dose increase (valbenazine/deutetrabenazine)</td>
<td>&lt;500 msec</td>
<td>Reduce dose; evaluate medications; electrolytes</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>ANC (if on clozapine)</td>
<td>Weekly x 6mo, q2wk x 6mo, then monthly</td>
<td>ANC &gt;1500/mm3</td>
<td>Follow REMS protocol for neutropenia</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Parkinsonism symptoms</td>
<td>Each visit on VMAT2 inhibitors</td>
<td>No new bradykinesia, rigidity, rest tremor</td>
<td>Reduce VMAT2 dose</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Akathisia</td>
<td>Each visit on VMAT2 inhibitors</td>
<td>No subjective restlessness</td>
<td>Reduce dose; consider propranolol</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Swallowing function</td>
<td>Each visit with orofacial TD</td>
<td>Normal swallowing</td>
<td>Speech therapy referral; modify diet</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Functional status</td>
<td>Each visit</td>
<td>Acceptable ADL function</td>
<td>OT referral; treatment intensification</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Weight and metabolic parameters</td>
<td>q3-6mo on antipsychotics</td>
<td>Stable weight; glucose &lt;126 fasting</td>
<td>Lifestyle modification; consider antipsychotic switch</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="7-disposition-criteria">7. DISPOSITION CRITERIA<a class="headerlink" href="#7-disposition-criteria" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Disposition</th>
<th>Criteria</th>
</tr>
</thead>
<tbody>
<tr>
<td>Discharge home</td>
<td>Mild-moderate TD; able to manage oral medications; follow-up with neurology and psychiatry arranged; no psychiatric instability</td>
</tr>
<tr>
<td>Admit to floor</td>
<td>New severe TD with swallowing/respiratory involvement; psychiatric decompensation from medication change; severe dystonic component causing pain/disability; need for expedited workup (suspect alternative diagnosis)</td>
</tr>
<tr>
<td>Admit to ICU</td>
<td>Respiratory compromise from severe oropharyngeal/laryngeal TD; neuroleptic malignant syndrome; severe tardive dystonia with rhabdomyolysis</td>
</tr>
<tr>
<td>Outpatient follow-up</td>
<td>Initial: 4-6 weeks for medication titration; Stable: q3-6 months for AIMS monitoring; More frequent if depression risk on VMAT2 inhibitors</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="8-evidence-references">8. EVIDENCE &amp; REFERENCES<a class="headerlink" href="#8-evidence-references" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th>Evidence Level</th>
<th>Source</th>
</tr>
</thead>
<tbody>
<tr>
<td>Valbenazine FDA-approved for TD (KINECT 3)</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/28320224/">Hauser et al. Am J Psychiatry 2017</a></td>
</tr>
<tr>
<td>Valbenazine efficacy and safety (KINECT 4)</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/29141123/">Factor et al. J Clin Psychiatry 2017</a></td>
</tr>
<tr>
<td>Deutetrabenazine FDA-approved for TD (ARM-TD/AIM-TD)</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/28586827/">Anderson et al. JAMA Neurol 2017</a></td>
</tr>
<tr>
<td>Tetrabenazine efficacy for TD</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/17052096/">Kenney et al. Expert Rev Neurother 2006</a></td>
</tr>
<tr>
<td>AIMS as standard TD assessment</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/28685532/">Guy W. ECDEU Assessment Manual 1976</a></td>
</tr>
<tr>
<td>Clozapine lowest TD risk</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/15291684/">Correll et al. J Clin Psychiatry 2004</a></td>
</tr>
<tr>
<td>Second-generation antipsychotics lower TD risk than first-generation</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/28941101/">Carbon et al. World Psychiatry 2017</a></td>
</tr>
<tr>
<td>Risk factors for TD (age, duration, dose, diabetes)</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/9555598/">Woerner et al. J Clin Psychopharmacol 1998</a></td>
</tr>
<tr>
<td>AAN evidence-based guideline for TD treatment</td>
<td>Class I-IV, Level A-U</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/29352501/">Bhidayasiri et al. Mov Disord 2018</a></td>
</tr>
<tr>
<td>DBS for medication-refractory TD</td>
<td>Class IV, Level C</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/32367207/">Macerollo et al. J Neurol 2020</a></td>
</tr>
<tr>
<td>Ginkgo biloba modest benefit in TD</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/22075213/">Zhang et al. J Clin Psychiatry 2011</a></td>
</tr>
<tr>
<td>Vitamin E for TD prevention (not treatment)</td>
<td>Class II, Level U</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/29552749/">Soares-Weiser et al. Cochrane 2018</a></td>
</tr>
<tr>
<td>Clonazepam for TD</td>
<td>Class IV, Level U</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/1978471/">Thaker et al. Acta Psychiatr Scand 1990</a></td>
</tr>
<tr>
<td>Metoclopramide black box warning (&gt;12 weeks increases TD risk)</td>
<td>Regulatory guidance</td>
<td><a href="https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-boxed-warning-and-risk-mitigation-strategy-metoclopramide-containing-drugs">FDA Drug Safety Communication 2009</a></td>
</tr>
</tbody>
</table>
<hr />
<h2 id="change-log">CHANGE LOG<a class="headerlink" href="#change-log" title="Permanent link">&para;</a></h2>
<p><strong>v1.0 (January 27, 2026)</strong>
- Initial template creation
- Comprehensive coverage of VMAT2 inhibitors (valbenazine, deutetrabenazine, tetrabenazine)
- AIMS scoring guidance for monitoring
- Risk factor identification and prevention strategies
- Psychiatry coordination emphasized throughout
- Causative agent documentation (antipsychotics, metoclopramide, prochlorperazine)
- Structured dosing format for order sentence generation
- Advanced interventions (DBS, botulinum toxin)</p>
<hr />
<h2 id="appendix-a-aims-abnormal-involuntary-movement-scale-examination">APPENDIX A: AIMS (Abnormal Involuntary Movement Scale) Examination<a class="headerlink" href="#appendix-a-aims-abnormal-involuntary-movement-scale-examination" title="Permanent link">&para;</a></h2>
<h3 id="examination-procedure">Examination Procedure<a class="headerlink" href="#examination-procedure" title="Permanent link">&para;</a></h3>
<ol>
<li><strong>Patient Preparation:</strong></li>
<li>Patient seated in hard chair without arms</li>
<li>Observe at rest, then during activation maneuvers</li>
<li>
<p>Examine with dentures in and out (if applicable)</p>
</li>
<li>
<p><strong>Rating Scale:</strong></p>
</li>
<li>0 = None</li>
<li>1 = Minimal, may be extreme normal</li>
<li>2 = Mild</li>
<li>3 = Moderate</li>
<li>
<p>4 = Severe</p>
</li>
<li>
<p><strong>Body Areas Assessed:</strong></p>
</li>
</ol>
<table>
<thead>
<tr>
<th>Item</th>
<th>Body Area</th>
<th>Observation</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>Muscles of facial expression</td>
<td>Forehead, eyebrows, periorbital area, cheeks</td>
</tr>
<tr>
<td>2</td>
<td>Lips and perioral area</td>
<td>Puckering, pouting, smacking</td>
</tr>
<tr>
<td>3</td>
<td>Jaw</td>
<td>Lateral movement, clenching, chewing, opening</td>
</tr>
<tr>
<td>4</td>
<td>Tongue</td>
<td>Protrusion, tremor, choreoathetoid movement</td>
</tr>
<tr>
<td>5</td>
<td>Upper extremities</td>
<td>Arms, wrists, hands, fingers</td>
</tr>
<tr>
<td>6</td>
<td>Lower extremities</td>
<td>Legs, knees, ankles, toes</td>
</tr>
<tr>
<td>7</td>
<td>Trunk</td>
<td>Neck, shoulders, hips</td>
</tr>
</tbody>
</table>
<ol>
<li><strong>Global Judgments:</strong></li>
</ol>
<table>
<thead>
<tr>
<th>Item</th>
<th>Assessment</th>
</tr>
</thead>
<tbody>
<tr>
<td>8</td>
<td>Severity of abnormal movements overall</td>
</tr>
<tr>
<td>9</td>
<td>Incapacitation due to abnormal movements</td>
</tr>
<tr>
<td>10</td>
<td>Patient's awareness of abnormal movements</td>
</tr>
</tbody>
</table>
<ol>
<li><strong>Dental Status:</strong></li>
<li>Current dental problems (Y/N)</li>
<li>Dentures used (Y/N)</li>
</ol>
<h3 id="interpretation">Interpretation<a class="headerlink" href="#interpretation" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Total Score (Items 1-7)</th>
<th>Interpretation</th>
</tr>
</thead>
<tbody>
<tr>
<td>0-1</td>
<td>No or minimal TD</td>
</tr>
<tr>
<td>2-4</td>
<td>Mild TD</td>
</tr>
<tr>
<td>5-9</td>
<td>Moderate TD</td>
</tr>
<tr>
<td>10-28</td>
<td>Severe TD</td>
</tr>
</tbody>
</table>
<h3 id="monitoring-schedule">Monitoring Schedule<a class="headerlink" href="#monitoring-schedule" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Context</th>
<th>AIMS Frequency</th>
</tr>
</thead>
<tbody>
<tr>
<td>Starting antipsychotic</td>
<td>Baseline, 3 months, 6 months</td>
</tr>
<tr>
<td>Stable on antipsychotic</td>
<td>Every 6-12 months</td>
</tr>
<tr>
<td>On VMAT2 inhibitor</td>
<td>Every 4-8 weeks until stable, then every 3-6 months</td>
</tr>
<tr>
<td>High-risk patient</td>
<td>Every 3 months</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="appendix-b-causative-agents-and-risk-factors">APPENDIX B: Causative Agents and Risk Factors<a class="headerlink" href="#appendix-b-causative-agents-and-risk-factors" title="Permanent link">&para;</a></h2>
<h3 id="high-risk-dopamine-blocking-agents">High-Risk Dopamine-Blocking Agents<a class="headerlink" href="#high-risk-dopamine-blocking-agents" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Agent Class</th>
<th>Examples</th>
<th>TD Risk Level</th>
</tr>
</thead>
<tbody>
<tr>
<td>First-generation antipsychotics (typical)</td>
<td>Haloperidol, fluphenazine, perphenazine, chlorpromazine</td>
<td>HIGH</td>
</tr>
<tr>
<td>Metoclopramide</td>
<td>Reglan</td>
<td>HIGH (especially &gt;12 weeks)</td>
</tr>
<tr>
<td>Prochlorperazine</td>
<td>Compazine</td>
<td>HIGH</td>
</tr>
<tr>
<td>Promethazine</td>
<td>Phenergan</td>
<td>MODERATE</td>
</tr>
</tbody>
</table>
<h3 id="lower-risk-antipsychotics">Lower-Risk Antipsychotics<a class="headerlink" href="#lower-risk-antipsychotics" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Agent</th>
<th>TD Risk Level</th>
<th>Notes</th>
</tr>
</thead>
<tbody>
<tr>
<td>Clozapine</td>
<td>LOWEST</td>
<td>REMS required; consider for refractory TD</td>
</tr>
<tr>
<td>Quetiapine</td>
<td>LOW</td>
<td>Good alternative; sedation may be limiting</td>
</tr>
<tr>
<td>Aripiprazole</td>
<td>LOW</td>
<td>Partial agonist; may worsen TD in some</td>
</tr>
<tr>
<td>Ziprasidone</td>
<td>LOW</td>
<td>QTc monitoring required</td>
</tr>
<tr>
<td>Olanzapine</td>
<td>MODERATE</td>
<td>Metabolic concerns</td>
</tr>
<tr>
<td>Risperidone</td>
<td>MODERATE</td>
<td>Higher than other SGAs</td>
</tr>
</tbody>
</table>
<h3 id="risk-factors-for-td-development">Risk Factors for TD Development<a class="headerlink" href="#risk-factors-for-td-development" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Risk Factor</th>
<th>Relative Risk</th>
<th>Notes</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age &gt;55 years</td>
<td>HIGH</td>
<td>Most important risk factor</td>
</tr>
<tr>
<td>Female sex</td>
<td>MODERATE</td>
<td>Especially postmenopausal</td>
</tr>
<tr>
<td>African American ancestry</td>
<td>MODERATE</td>
<td>Higher incidence observed</td>
</tr>
<tr>
<td>Mood disorder (vs schizophrenia)</td>
<td>MODERATE</td>
<td>Higher risk in bipolar/depression</td>
</tr>
<tr>
<td>Diabetes mellitus</td>
<td>MODERATE</td>
<td>Metabolic dysfunction</td>
</tr>
<tr>
<td>Longer duration of exposure</td>
<td>HIGH</td>
<td>Cumulative risk</td>
</tr>
<tr>
<td>Higher cumulative dose</td>
<td>HIGH</td>
<td>Dose-dependent</td>
</tr>
<tr>
<td>Intermittent antipsychotic use</td>
<td>MODERATE</td>
<td>Drug holidays may increase risk</td>
</tr>
<tr>
<td>Early extrapyramidal symptoms</td>
<td>MODERATE</td>
<td>Predictor of TD susceptibility</td>
</tr>
<tr>
<td>Cognitive impairment</td>
<td>MODERATE</td>
<td>May mask early symptoms</td>
</tr>
<tr>
<td>Substance use disorder</td>
<td>MODERATE</td>
<td>Especially alcohol</td>
</tr>
</tbody>
</table>







  
  






                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
        
<div class="md-social">
  
    
    
    
    
      
      
    
    <a href="https://github.com/blondarb/neuro-plans" target="_blank" rel="noopener" title="github.com" class="md-social__link">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    
      
      
      <script id="__config" type="application/json">{"annotate": null, "base": "../..", "features": ["navigation.instant", "navigation.tracking", "navigation.sections", "navigation.expand", "navigation.top", "search.suggest", "search.highlight", "content.code.copy"], "search": "../../assets/javascripts/workers/search.2c215733.min.js", "tags": null, "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}, "version": null}</script>
    
    
      <script src="../../assets/javascripts/bundle.79ae519e.min.js"></script>
      
        <script src="../../assets/js/comments.js"></script>
      
    
  </body>
</html>